Integrative surfaceome profiling identifies immunotherapeutic targets in osteosarcomas (OS); Preclinical testing of BT1769, an MT1-MMP-targeted Bicycle Toxin Conjugate, in OS by the Pediatric Preclinical Testing Consortium (PPTC).

Wang, YF; Zhang, WD; Zhang, ZT; Tian, XJ; Segura, RNL; Hingorani, P; Roth, M; Gill, J; Harrison, D; Xu, ZH; Wang, J; Earley, EJ; Erickson, SW; Kolb, EA; Smith, MA; Houghton, P; Kurmasheva, R; Gelb, T; Huxley, P; Lahdenranta, J; Mudd, G; Gorlick, R

CANCER RESEARCH, 2021; 81 (13):